MedTrace Logo

the Effect of High Dose Ascorbic Acid on Critically Ill Patients With ARDS

NCT03780933 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2019-10-02

No results posted yet for this study

Summary

1. To access role of vitamin C supplementation in ARDS patients on the following:

Oxidants/ antioxidants imbalance Length of hospital stay Mortality rate Weaning from mechanical ventilator Incidence of adverse drug reaction
2. To access tolerability of vitamin C supplementation in patients with ARDS.

Conditions

  • Acute Respiratory Distress

Interventions

DIETARY_SUPPLEMENT

vitamin c

vitamin c IV 10 G

Sponsors & Collaborators

  • Misr International University

    lead OTHER

Principal Investigators

  • Nada Farrag, Msc · Misr International University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-05
Primary Completion
2019-06-20
Completion
2019-06-20

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03780933 on ClinicalTrials.gov